ASX 200 technology and healthcare shares continued their comeback last week

ASX 200 tech stocks rose 8.2% and healthcare increased 5.5% over the week.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX 200 tech shares led the 11 market sectors last week, soaring 8.2% as its comeback continued.

Healthcare shares weren't far behind with a 5.5% gain, making this another impressive week for the rebounding sector.

Meanwhile, the S&P/ASX 200 Index (ASX: XJO) surged 2.3% to close at 8,976.8 points on Friday.

A better-than-expected inflation report last week reduced the risk of the Reserve Bank raising interest rates again on 11 August.

This, along with more oil tankers getting through the Strait of Hormuz, provided substantial tailwinds for the market last week.

All but one of the 11 market sectors finished the week in the green.

Let's review.

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.

Image source: Getty Images

ASX 200 tech shares and healthcare outperform

ASX 200 tech shares are continuing to recover from a 48% sector meltdown between 29 August 2025 and 30 March this year.

Stretched valuations and fears that massive artificial intelligence (AI) capex spending would fail to yield high returns drove the downturn.

The S&P/ASX 200 Information Technology Index (ASX: XIJ) is now up 17% since 30 March vs. a 6.1% lift for the broader ASX 200.

Last week, ASX 200 tech shares were buoyed Microsoft Corp's (NASDAQ: MSFT) 15.5% rise on Thursday.

That was the biggest single-day increase for Microsoft shares ever.

The price jump followed the company's 4Q FY26 report, which revealed more than US$100 billion in annual revenue for Azure.

Among last week's best-performing ASX 200 tech shares was WiseTech Global Ltd (ASX: WTC), up 20.9% to $36.30.

The Xero Ltd (ASX: XRO) share price rose 13.7% to $70 per share on Friday.

TechnologyOne Ltd (ASX: TNE) shares rose 13.5% to $30.76 apiece.

The Life360 Inc (ASX: 360) share price ascended 11.1% to $25.64.

Healthcare shares fell 39% over the 12 months to 3 June, when the S&P/ASX 200 Health Care Index (ASX: XHJ) hit a 9-year low.

The sector's downward spiral was due to many industry headwinds, including currency challenges for companies reporting in US dollars, cost-of-living pressures prompting patients to delay treatments and product purchases, higher shipping costs due to the US-Iran war, new caps on insurance payouts in some nations, higher staff wages, and US regulatory uncertainty impacting the biotechs.

Value investors have swooped on healthcare shares since 3 June, with the sector up 19% versus a 2.2% lift for the benchmark index.  

Last week, CSL Ltd (ASX: CSL) shares rose 7.7% to finish at $123.06 on Friday. 

Shares in Chemist Warehouse owner, Sigma Healthcare Ltd (ASX: SIG), rose 3.5% to $2.94.

Resmed CDI (ASX: RMD) shares ascended 8.6% to $29.79.

Sonic Healthcare Ltd (ASX: SHL) shares rose 3% to $21.86 and Cochlear Ltd (ASX: COH) increased 7.5% to $119.94.

ASX 200 market sector snapshot

Here's how the 11 market sectors stacked up last week, according to CommSec data.

Over the five trading days:

S&P/ASX 200 market sectorChange last week
Information Technology (ASX: XIJ)8.19%
Healthcare (ASX: XHJ)5.54%
Consumer Discretionary (ASX: XDJ)4.14%
Communication (ASX: XTJ)4.1%
A-REIT (ASX: XPJ)3.53%
Consumer Staples (ASX: XSJ)2.17%
Materials (ASX: XMJ)1.84%
Financials (ASX: XFJ)1.78%
Industrials (ASX: XNJ)1.52%
Utilities (ASX: XUJ)0.18%
Energy (ASX: XEJ)(0.54%)

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Cochlear, Life360, Microsoft, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended Life360, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has recommended CSL, Cochlear, Microsoft, and Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Broker written in white with a man drawing a yellow underline.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Male doctor in a lab coat working at laptop looking serious.
Broker Notes

Buy, hold, sell: What is Bell Potter saying about CSL shares?

Bell Potter has been looking at the biotech giant ahead of its results release.

Read more »

A bored woman looking at her computer, it's bad news.
Share Fallers

These were the worst-performing ASX 200 shares in July

These shares had a tough time in July. Let's find out why.

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Buy, hold, sell: Newmont, Rio Tinto, and Santos shares

Morgans has updated its view on these mining shares.

Read more »

Happy work colleagues give each other a fist pump.
Share Gainers

These were the best-performing ASX 200 shares in July

These shares had a month to remember. Let's find out why.

Read more »

Male investor holds a magnifying glass to his eye.
Broker Notes

Brokers name 3 ASX shares to buy in August

Three broker buy ratings worth a closer look this month.

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX scraped a win this Friday to close the week.

Read more »

A man dressed in a business suit freefalls from a rocky cliff with a grey sky background.
Share Fallers

Why these 3 ASX 200 stocks are crashing in this week's surging market

Investors sent these three ASX 200 shares tumbling 15% to 18% in this week’s rising market. But why?

Read more »